Evidence map›Paper›PMID 26614180›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2015

Expanding human immunodeficiency virus testing and counseling to reach tuberculosis clients' partners and families.

C Courtenay-Quirk, A Date, P Bachanas, R Baggaley, H Getahun, L Nelson, R Granich

Abstract read
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

C Courtenay-QuirkDivision of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
A DateDivision of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
P BachanasDivision of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
R BaggaleyWorld Health Organization, Geneva, Switzerland.
H GetahunWorld Health Organization, Geneva, Switzerland.
L NelsonWorld Health Organization, Geneva, Switzerland.
R GranichInternational Association of Providers of AIDS Care, Washington DC, USA.

Funding

Intramural CDC HHS CC999999PEPFARWorld Health Organization 001
6 · The paper itself

Abstract

Recent years have shown important increases in human immunodeficiency virus (HIV) testing and counseling (HTC), diagnosis, and coverage of antiretroviral therapy (ART) among HIV-infected tuberculosis (TB) patients. Expansion of HTC for partners and families are critical next steps to increase earlier HIV diagnoses and access to ART, and to achieve international goals for reduced TB and HIV-related morbidity, mortality, transmission and costs. TB and HIV programs should develop and evaluate feasible and effective strategies to increase access to HTC among the partners and families of TB patients, and ensure that newly diagnosed people living with HIV and HIV-infected TB patients who complete anti-tuberculosis treatment are successfully linked to ongoing HIV clinical care.

Indexed as

AIDS SerodiagnosisCounselingAntiretroviral Therapy, Highly ActiveFamilyHIV InfectionsHumansSexual PartnersTanzaniaTuberculosis

Identifiers

PMID26614180
PMCPMC4756587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.